Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s latest show of support for weight-loss drugs as he has pushed for making them more accessible to the general public.

To accomplish these goals, it's fair to assume that some people will ultimately turn to weight-loss drugs such as Ozempic and Mounjaro (which are only approved to treat type 2 diabetes but are often prescribed off-label) or Wegovy and Zepbound,

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.